Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A2 | P23975 | 9/20 | 0.49 |
| ▸ | SLC6A4 | P31645 | 9/20 | 0.49 |
| ▸ | SLC6A3 | Q01959 | 9/20 | 0.49 |
| ▸ | CYP1A1 | P04798 | 6/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 6/20 | 0.36 |
| ▸ | CYP2D6 | P10635 | 6/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 5/20 | 0.36 |
| ▸ | KCNH2 | Q12809 | 4/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.33 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.33 |
| ▸ | IRAK4 | Q9NWZ3 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8802483 | 0.94 | SLC6A2 (0.43) | SLC6A2SLC6A4SLC6A3CYP1A1CYP1A2 | |
| Hydrochloric Acid SCHEMBL22532128 | 0.92 | SLC6A2 (0.42) | SLC6A2SLC6A4SLC6A3CYP1A1CYP1A2 | |
| SCHEMBL21480118 | 0.81 | SLC6A2 (0.49) | SLC6A2SLC6A4SLC6A3CYP1A1CYP1A2 | |
| SCHEMBL19779541 | 0.81 | SLC6A2 (0.49) | SLC6A2SLC6A4SLC6A3CYP1A1CYP1A2 | |
| SCHEMBL21460159 | 0.81 | SLC6A2 (0.49) | SLC6A2SLC6A4SLC6A3CYP1A1CYP1A2 | |
| SCHEMBL16599675 | 0.77 | KDM4E (0.32) | — | |
| SCHEMBL18955033 | 0.77 | KDM4E (0.32) | — | |
| SCHEMBL331381 | 0.74 | EPHX1 (0.32) | CYP1A2 | |
| SCHEMBL5183304 | 0.74 | EPHX1 (0.32) | CYP1A2 | |
| SCHEMBL19315953 | 0.74 | EPHX1 (0.32) | CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11033547-B2 | Carboxamide-pyrimidine derivatives as SHP2 antagonists | MERCK PATENT GMBH (DE) | 2021-06-15 | — | — | US | disclosed |
| US-20200281926-A1 | CARBOXAMIDE-PYRIMIDINE DERIVATIVES AS SHP2 ANTAGONISTS | MERCK PATENT GMBH (DE) | 2020-09-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11033547-B2 | Carboxamide-pyrimidine derivatives as SHP2 antagonists | PTPN5, PTPN2, PTPN1 | SLC6A2 4629/4885SLC6A4 4485/4885SLC6A3 4435/4885 |
| US-20200281926-A1 | CARBOXAMIDE-PYRIMIDINE DERIVATIVES AS SHP2 ANTAGONISTS | PTPN5, PTPN2, PTPN1 | SLC6A2 4629/4885SLC6A4 4485/4885SLC6A3 4435/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.